Investor Type | Firm |
Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B |
Investing | United States • United Kingdom • Mexico • Israel • Brazil |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Black Opal Ventures is an investment fund that champions a more inclusive venture capital ecosystem, focusing on companies leveraging technology to address global challenges. Co-founded in 2021 by Tara Bishop and Eileen Tanghal, alumni of MIT with extensive backgrounds in healthcare, technology, and venture capital, the fund aims to catalyze change by backing transformative companies at the intersection of healthcare and technology. With investment capacities ranging from $100,000 to $5,000,000 and a sweet spot of approximately $1,500,000, Black Opal Ventures positions itself as a pivotal supporter for startups from Seed to Series B stages. The fund's thesis is rooted in the belief that the convergence of healthcare knowledge and tech innovations can lead to industry-transforming outcomes, reflecting exponential impact and returns. As healthcare spending in the U.S. skyrockets, anticipated to surpass $6 trillion by 2028, Black Opal Ventures seeks startups that offer innovative solutions to the sector's numerous unresolved issues. Besides financial performance, they measure success based on two additional primary dimensions: improvements in global health outcomes and advances in diversity. By intentionally operating at the collision point of healthcare and technology, which includes BioTech, FinTech, HealthTech, Fitness, Logistics, Medical Devices, Hospital Services, Healthcare, Wellness, and the Pharmaceutical sectors, Black Opal Ventures supports companies poised to solve some of the world's most pressing problems.